Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 03, 2022

SELL
$22.96 - $36.45 $250,264 - $397,305
-10,900 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$18.14 - $23.29 $509,734 - $654,449
-28,100 Reduced 72.05%
10,900 $254,000
Q3 2021

Nov 12, 2021

BUY
$17.83 - $21.49 $338,769 - $408,309
19,000 Added 95.0%
39,000 $741,000
Q2 2021

Aug 11, 2021

BUY
$17.11 - $20.92 $342,200 - $418,400
20,000 New
20,000 $403,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Factorial Partners, LLC Portfolio

Follow Factorial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.